INTERVIEW

Performing a gene and cell therapy trial for heart attack patients: an interview with Duncan Stewart

​In this interview, Dr. Duncan Stewart from the Ontario Institute for Regenerative Medicine discusses his ongoing ENACT-AMI trial studying angiogenic cell therapy to promote repair after a massive heart attack using eNOS-enhanced EPCs.

Go to the profile of RegMedNet
Sep 10, 2018
0
0
Like 0 Comment

In this interview, filmed at the 2018 annual meeting of the International Society of Cell and Gene Therapy (ISCT)(Montreal, QC, Canada), Dr. Duncan Stewart from the Ontario Institute for Regenerative Medicine discusses his ongoing ENACT-AMI trial studying angiogenic cell therapy to promote repair after a massive heart attack using eNOS-enhanced EPCs. Duncan also shares his thoughts on whether regenerative medicine has lived up to its hype.

Learn more about:
Go to the profile of RegMedNet

RegMedNet

eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.